Mission

Our mission is cure all patients with histiocytic diseases and optimize outcomes through innovative and collaborative research.

Goals

• To develop a network for the advancement of clinical, translational, and basic research in histiocytic diseases.
• To advance therapeutic, etiological and mechanistic research through the implementation of high impact clinical trials and organized collection of well annotated clinical data and biology specimens.
• To define the pathogenesis of histiocytic diseases and develop risk-stratification strategies with tissue samples from patients treated on NACHO trials.